The Cancer Research & Treatment Fund (CR&T) is proud to host the 12th International Patient Symposium for individuals with myeloproliferative neoplasms (MPNs), their family, and friends.

Patients and guests attending this day-long symposium will learn about the latest research developments and treatment practices from distinguished MPN researchers and physicians. This is a unique opportunity to engage with guest speakers from the most prestigious cancer centers in the world.

Speakers/Topics include:

• Drivers of Progression of MPNs: Ronald Hoffman, M.D.
• Managing Essential Thrombocythemia in 2023: Ellen K. Ritchie, M.D.
• The Microbiomes in the MPNs: Hans Hasselbalch, M.D., Ph.D.
• Managing Polycythemia Vera in 2023: Richard T. Silver, M.D.
• Inflammation in MPNs: Angela Fleischman, M.D., Ph.D.
• Managing Myelofibrosis in 2023: Jerry L. Spivak, M.D.
• Promising new drugs for MPN therapy: Naveen Pemmaraju, M.D.
• Demystifying bone marrow transplant for MPNs: Roni Tamari, M.D.
• Moderated Q&A: Ghaith Abu-Zeinah, M.D. - Moderator, and Entire Panel 
•  Disease-Specific Q&A Groups (moderated by Symposium presenters):   
  • Polycythemia Vera - Drs. Abu-Zeinah, Hasselbach, Hoffman, and Silver
  • Essential Thrombocythemia - Drs. Fleischman, Ritchie, and Schafer
  • Myelofibrosis - Drs. Pemmaraju, Spivak, and Tamari

Registration Includes:

• Continental Breakfast
• Conference program and materials 
• Access to all sessions
• Morning and afternoon coffee/snack breaks
• Access to sponsor tables
• Box Lunch
• Admission to the evening wine/cheese reception
• Discount code to MPN Congress

Scholarships available. Please contact Chad Feay at cfeay@crt.org for assistance.

Dress: Business casual